Potential targets for developing new therapies for allergic diseases include IgE, TH2 lymphocytes and TH2-derived cytokines, IL-4 and IL-5, and activated mast cells releasing bioactive allergy mediators (histamine, tumor necrosis factor, prostaglandin D2, etc.)[158,159,160]. This evidence concerns the gene IL5 and allergic disease.